BTIG analyst Marie Thibault raised the firm’s price target on iRhythm (IRTC) to $135 from $120 and keeps a Buy rating on the shares after its better than expected Q4 results. The company’s sales beat was driven by strong volume growth from all customer channels and a record quarter of new account openings for both Zio Monitor and Zio AT, with the quarter also being helped by a disruption in a competitor’s MCT business as well as a new innovative channel partner that opened in the quarter, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- Strong Sales Growth and Strategic Expansion Drive Buy Rating for iRhythm Technologies
- iRhythm price target raised to $104 from $86 at Wells Fargo
- iRhythm Technologies Reports Robust 2024 Growth
- iRhythm sees FY25 revenue $675M-$685M, consensus $679.42M
- iRhythm reports Q4 adjusted EPS 1c, consensus (24c)
Questions or Comments about the article? Write to editor@tipranks.com